NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

I agree poly-iclc will likely always be included.

Hear is something from UCLA’s Dr. Antonios at SNO 2018.

Dr. Antonios concluded that the findings suggested that the adjuvant TLR-3 agonist was shown to improve outcomes of autologous lysate-pulsed dendritic cell vaccine.

“Our findings were intriguing,” he said. “Not only does adjuvant treatment with poly ICLC promote T cell activation, but it also results in shifts in immune monocytic and B cell populations.”

“As we move forward with our studies,” Dr. Antonios added, “we will work to understand these mechanisms better and refine these treatments further as we introduce them to our patients with glioblastoma.”